menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease

2 0
20.01.2025
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 receptor agonists.

© Fortune